Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,208) with videos related to
Page
of 121
Sort By:
International Journal of Antimicrobial Agents
|
October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii
Justin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model
Phillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
March 10, 2010
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model
Jürgen B Bulitta, Jenny C Yang, Liliana Yohonn, et al.
Biochemical and Biophysical Research Communications
|
March 20, 1999
Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene
X Zhang, H Tsao, T Tsuji, et al.
International Journal of Antimicrobial Agents
|
December 10, 2016
In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing Escherichia coli in a hollow-fibre infection model
Rachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Journal of Pharmaceutical Sciences
|
October 25, 2023
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula
Jürgen B Bulitta, Eunjeong Shin, Phillip J Bergen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Actual invasive potential of human hepatocellular carcinoma revealed by in situ gelatin zymography
T Kaneyoshi, H Nakatsukasa, T Higashi, et al.
Antimicrobial Agents and Chemotherapy
|
January 6, 2016
Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations
Rachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy
|
March 2, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
Neang S Ly, Zackery P Bulman, Jürgen B Bulitta, et al.
Clinical and Experimental Immunology
|
February 5, 1999
Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1
Y Lu, K Q Xin, K Hamajima, et al.
Page
of 121
Search research articles
Search
Showing results (1061-1070 of 1,208) with videos related to
Sort By:
Page
of 121
International Journal of Antimicrobial Agents
|
October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii
Justin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model
Phillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
March 10, 2010
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model
Jürgen B Bulitta, Jenny C Yang, Liliana Yohonn, et al.
Biochemical and Biophysical Research Communications
|
March 20, 1999
Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related gene
X Zhang, H Tsao, T Tsuji, et al.
International Journal of Antimicrobial Agents
|
December 10, 2016
In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing Escherichia coli in a hollow-fibre infection model
Rachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Journal of Pharmaceutical Sciences
|
October 25, 2023
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula
Jürgen B Bulitta, Eunjeong Shin, Phillip J Bergen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Actual invasive potential of human hepatocellular carcinoma revealed by in situ gelatin zymography
T Kaneyoshi, H Nakatsukasa, T Higashi, et al.
Antimicrobial Agents and Chemotherapy
|
January 6, 2016
Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations
Rachel L Soon, Justin R Lenhard, Zackery P Bulman, et al.
Antimicrobial Agents and Chemotherapy
|
March 2, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
Neang S Ly, Zackery P Bulman, Jürgen B Bulitta, et al.
Clinical and Experimental Immunology
|
February 5, 1999
Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1
Y Lu, K Q Xin, K Hamajima, et al.
Page
of 121